The specific objectives of this funding opportunity are to:

• Improve the understanding of the causes, defining measures, and avenues for prevention, detection and management of sleep deprivation and insomnia, including in the context of health disparities, and Indigenous Peoples' health and well-being, through coordinated data collection and research activities across the CIHR research pillars to co-create new knowledge and technical and scientific expertise;
• Accelerate the iterative, bi-directional translation of research results and evidence into practice for improved health and well-being associated with poor sleep hygiene and insomnia;
• Develop, implement, evaluate, and validate interventions that foster improved sleep health and well-being as they relate to insomnia and sleep deprivation, evaluate outcomes of interventions, and accelerate the mobilization of research evidence of best, promising, and wise practices to bridge gaps between research outcomes and health impacts for the betterment of sleep; and
• Build, foster, and promote relevant sleep research capacity, including training, career development, and experiential opportunities through a high-quality, multidisciplinary capacity development and mentoring environment that actively engages trainees and researchers at all career stages and across  ethnicities, including Indigenous investigators.

Brain Canada and JDRF are pleased to officially launch the JDRF Canada – Brain Canada Addressing Mental Health in Type 1 Diabetes Team Grants, a program to support research on the development, validation, or implementation of interventions that address mental health concerns in people with type 1 diabetes. 

This new funding opportunity is open to research teams of two or more independent investigators from different institutions, or distinct departments within the same institution.

The JDRF Canada – Brain Canada Addressing Mental Health in Type 1 Diabetes Team Grants will offer two grants of up to $250,000 each over two years to fund the development and testing of sustainable, scalable approaches that will enable improved support for Canadians who live with type 1 diabetes and are affected by mental health disorders, and will translate into better quality of life and diabetes-related health outcomes for these populations.

Projects of interest include those that: 

• Focus on interventions (e.g., behavioral health, peer support, clinical algorithms, etc.) that support these populations
• Consider mental health disorders such as depression, eating disorders, diabetes distress, etc.
• Address high-risk groups of particular interest (e.g., children & adolescents, young adults, diverse populations, etc.)

Interested applicants will first be required to register a team by September 15, 2021 at 17:00 ET. Select applicants will be invited to proceed to the Full Application phase. The deadline to submit a Full Application is October 28, 2021 at 17:00 ET. 

Note: a webinar for interested applicants will be held via Zoom July 28 at 12:00 ET to register click here.

Increasing equity, diversity and inclusion (EDI) in research environments enhances excellence, innovation and creativity. JDRF Canada and Brain Canada are committed to excellence through equity, and we encourage applicants of diverse backgrounds to apply to our funding opportunities. 
 
Please refer to the Request for Applications for additional details.

The Sub Contractor must provide services to conduct a review of academic and applied research literature on psychological safety (and related concepts) in the workplace, with the focus on military and para-military organizations. In addition, the Sub Contractor must develop a scale that takes into account all of the key dimensions related to psychological safety (and related concepts) that can be included in a survey and administered to militarypersonnel.

The Challenge aims to support new innovations and solutions which can help address the problem of food waste and loss across the supply chain, thereby reducing the associated economic, environmental, and social costs of food waste. Collectively, these solutions will help increase food availability, save consumers and businesses money, reduce GHG emissions and improve the efficiency of the food sector.

The objectives of the Challenge are to:

• Reduce food waste in Canada;
• Foster improvements in food waste measurement;
• Attract new ideas, partners and resources to invest in solving the complex problem of food waste;
• Prompt new collaborations among non-traditional partners and problem solvers;
• Increase awareness of food waste among Canadians;
• Contribute to improving food security and creating jobs;
• Build the capacity of new innovators and support their entry into the market;
• Support the development of new industries, services and value-added goods; and
• Increase economic profitability and competitiveness of the Canadian agri-food sector.

Results achieved through the Challenge will also contribute towards Canada’s achievement of the UN Sustainable Development target of 50% reduction in food waste by 2030 and contribute to GHG emission reductions along the product life cycle.

• Stream C: Technologies that Extend the Life of Food (Open for applications in May 2021)
• Stream D: Technologies that Transform Food Waste (Open for applications in May 2021)

Stream C focuses on technologies that extend the life of perishable foods to reduce the creation of food waste by slowing the degradation mechanism of specific perishable food items and extending the length of time these food items may be stored without becoming unsuitable for use or consumption.

Stream D focuses on technologies that transform food waste by converting surplus food, food by-products, or food waste into other products, including: food for humans, food for animals/insects (e.g. animal feed), or non-food products.

Streams C and D focus on technologies that are at the prototype and testing phases to improve their effectiveness and make them ready for market within the next two years.

Women’s Brain Health Initiative (WBHI) and Brain Canada have joined forces to launch the first ever Brain Canada-WBHI Expansion Grants: Considering Sex and Gender Program, a new initiative to support the implementation or continuation of sex and gender considerations for research.  

Eligible projects include those that (1) have been previously funded by Brain Canada or WBHI, (2) have a grant end date in 2019 or later and (3) focus on aging, neurodegeneration or stroke. Six grants of up to $105,000 will be awarded for a total investment of $630,000 in the amplification of sex and gender-based research.   

The Brain Canada-WBHI Expansion Grants are designed to encourage researchers to incorporate sex and gender-based analysis (SGBA)-driven research hypotheses into their existing work by contributing to overcoming current barriers in research and creating a foundation for sex and gender considerations to become standard practice within the scientific community. 

Evidence clearly shows that increasing equity, diversity, and inclusion (EDI) in research environments enhances excellence, innovation, and creativity. Brain Canada and WBHI are committed to excellence through equity and encourage applicants of diverse backgrounds to apply to our funding opportunities. 

Interested applicants will first be required to register by July 5th, 2021 at 16:00 ET. Eligible applicants will be invited to proceed to the Full Application phase. The deadline for Full Applications through Brain Canada's electronic grant management system - SmartSimple is September 1st, 2021 at 16:00 ET.   

Please refer to the Request for Applications for additional details.

Aid to Scholarly Journals grants are expected to respond to the objectives of the Insight program. They support Canadian scholarly dissemination by offering a contribution to enable journals to explore innovative activities as well as to help them to defray the costs associated with publishing scholarly articles, digital publishing and journal distribution on Canadian not-for-profit platforms.

Aid to Scholarly Journals grants are meant to:

• increase dissemination, discoverability and readership of original research results in the social sciences and humanities through Canadian scholarly journals;
• leverage significant federal investments in digital scholarly publishing infrastructure;
• assist journals as they seek to take advantage of developments in digital technologies and innovative practices; and
• encourage the transition to open access models of publishing.

CIFAR invites the global research community to submit proposals for new programs that address complex, fundamental questions of importance to the world. Ideas must be novel, bold, and potentially transformative to warrant the creation of a sustained, interdisciplinary, and collaborative research program.

For CIFAR’s third Global Call for Ideas, we invite proposals related to The Future of Being Human, exploring the intersection of humans, science and technology, social and cultural systems, and our environment. Our understanding of the world around us, and new insights into individual and societal behaviour, have the potential to provide enormous benefits to humanity and the planet. We invite bold proposals that address over the long term novel questions about our complex emerging world, where the issues under study are entangled and dynamic. 

We are confronting challenging problems that necessitate a diverse team incorporating multiple disciplines (potentially spanning the humanities, social sciences, arts, physical and life sciences) to engage in sustained dialogue to develop new insights, and change the conversation on important questions facing science and humanity.

To learn more about the Global Call for Ideas, please visit cifar.ca/global-call.  Deadline for Registrations: August 17, 2021.

The FY21 Defense Appropriations Act provides funding to the Department of Defense Chronic Pain Management Research Program (CPMRP) to support research of exceptional scientific merit with the potential to make a significant impact on improving the health and quality of life of Service members, Veterans, and all Americans living with chronic pain.  Per the FY19 CPMRP Congressional appropriation, chronic pain is defined as a pain that occurs on at least half the days for six months or more, and which can be caused by issues including, but not limited to:  combat- and training-related physical or mental stress and trauma, migraines and chronic headaches, traumatic brain injury, arthritis, muscular-skeletal conditions, neurological disease, tick and vector-borne disease, other insect-transmitted or tropical disease, and cancer.  The CPMRP seeks to support and promote innovative, high-impact research to prevent the development and improve the management of chronic pain, with specific emphasis on the utilization and implementation of non-opioid therapies or non-addictive complementary methods.  The managing agent for the anticipated program announcements/funding opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC).

The FY21 CPMRP program announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website. 

Applications submitted to the FY21 CPMRP must address one or more of the following focus areas:

• Clinical Exploration Award
  • Chronification of pain (i.e., the acute-to-chronic pain transition)
  • Effectiveness or observational studies of novel techniques/approaches/pathways to chronic pain management
• Investigator Initiated Research Award
  • Chronification of pain (i.e., the acute-to-chronic pain transition)
  • Development of non-opioid therapies and methods for the treatment of chronic pain
  • Effectiveness or observational studies of novel or untested techniques/approaches/pathways to chronic pain management
• Translational Research Award
  • Comparative effectiveness studies (for evidence-based, efficacious interventions to manage or prevent chronic pain)
  • Implementation science (for evidence-based, efficacious interventions to manage or prevent chronic pain)
  • Observational studies

https://cdmrp.army.mil/funding/cpmrp

Clinical Exploration Award (new for FY21) – Preproposal due July 30, 2021

Independent Investigators at all levels

Supports proof-of-principle pilot studies, clinical trials, and correlative studies with the potential to resolve current clinical barriers.

• Research must address one or both of the FY21 CPMRP CEA Focus Areas of chronification of pain and effectiveness or observational studies of novel or untested techniques/approaches/pathways to chronic pain management.

• Preliminary data are not required for FY21 CPMRP CEA applications.

• Statistically underpowered studies of efficacy are not pilot studies and will not be supported under the FY21 CPMRP CEA mechanism.

• Pre-application submission is required; application submission is by invitation only.

Investigator-Initiated Research Award – Preproposal due July 30, 2021

Investigators at or above the level of Assistant Professor (or equivalent)

Supports innovative research that will make an original and important contribution to the field of research, patient care, and/or quality of life.

• Research must address one or more of the FY21 CPMRP IIRA Focus Areas of chronification of pain, development of non-opioid therapies and methods for the treatment of chronic pain, and effectiveness or observational studies of novel or untested techniques/approaches/pathways to chronic pain management.

• Partnering PI Option is available.

• Multidisciplinary collaborations and innovative approaches are encouraged.

• Clinical trials will not be funded.

• Pre-application submission is required; application submission is by invitation only.

• The maximum allowable funding for the entire period of performance is $900,000 for direct costs.

• Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.

• The maximum period of performance is 4 years.

Translational Research Award – Preproposal due July 30, 2021

Investigators at or above the level of Assistant Professor (or equivalent)

Supports translational research that will accelerate the movement of efficacious, evidence-based ideas into clinical applications.

• Research must address one or more of the FY21 CPMRP TRA Focus Areas of implementation science, comparative effectiveness, and observational studies related to chronic pain.

• Partnering PI Option is available.

• Incorporation of biopsychosocial models of assessment and stakeholder engagement are encouraged.

• Studies seeking to evaluate new therapies or approaches, either pharmacological or non-pharmacological, that have not been previously evaluated in a clinical setting will not be funded.

• Pre-application submission is required; application submission is by invitation only

The maximum allowable funding for the entire period of performance is $1,400,000 for direct costs.

• Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.

• The maximum period of performance is 4 years.

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  All applications must conform to the final program announcements and General Application Instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

For email notification when program announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the CPMRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).

Point of Contact:

CDMRP Help Desk
301-682-5507
help@eBrap.org